Stratification of rate of lymph node metastasis according to risk factors and oncologic outcomes in patients who underwent radical resection for rectal neuroendocrine tumors
10.3393/ac.2022.00913.0130
- Author:
Myung Jae JIN
1
;
Sung Sil PARK
;
Dong-Eun LEE
;
Sung Chan PARK
;
Dong Woon LEE
;
Kiho YOU
;
Hee Jin CHANG
;
Chang Won HONG
;
Dae Kyung SOHN
;
Kyung Su HAN
;
Bun KIM
;
Byung Chang KIM
;
Jae Hwan OH
Author Information
1. Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
- Publication Type:Original Article
- From:Annals of Coloproctology
2023;39(6):467-473
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:Most predictive factors for lymph node metastasis in rectal neuroendocrine tumors (NETs) have been based on local and endoscopic resection. We aimed to evaluate the risk factors for lymph node metastasis in patients who underwent radical resection for rectal NETs and stratify the risk of lymph node metastasis.
Methods:Sixty-four patients who underwent radical resection for rectal NETs between January 2001 and January 2018 were included. We investigated the risk factors of lymph node metastasis using clinicopathologic data. We also performed a risk stratification for lymph node metastases using the number of previously known risk factors. For oncologic outcomes, the 5-year overall survival and recurrence-free survival were evaluated in both groups.
Results:Among the patients who underwent radical surgery, 32 (50.0%) had lymph node metastasis and 32 (50.0%) had non–lymph node metastasis. In the multivariable analysis, only the male sex was identified as a risk factor for lymph node metastasis (odds ratio, 3.695; 95% confidence interval, 1.128–12.105; P=0.031). When there were 2 or more known risk factors, the lymph node metastasis rate was significantly higher than when there were one or no risk factors (odds ratio, 3.667; 95% confidence interval, 1.023–13.143; P=0.046). There was also no statistical difference between the 2 groups in 5-year overall survival (P=0.431) and 5-year recurrence-free survival (P=0.144).
Conclusion:We found that the rate of lymph node metastasis increased significantly when the number of known risk factors is 2 or more.
